wegovy
novo nordisk a/s - semaglutid - obesity; overweight - preparati za zaščito proti sončenju, prehrambeni izdelki - wegovy is indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in adults with an initial body mass index (bmi) of- ≥30 kg/m² (obesity), or- ≥27 kg/m² to.
lenalidomide krka (previously lenalidomide krka d.d. novo mesto)
krka, d.d., novo mesto - lenalidomide hydrochloride monohydrate - multiple myeloma; myelodysplastic syndromes; lymphoma, follicular; lymphoma, mantle-cell - imunosupresivi - multiple myelomalenalidomide krka as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) je indiciran za zdravljenje odraslih bolnikov s predhodno nezdravljenih več plazmocitom, ki niso primerni za presaditev. lenalidomide krka in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. myelodysplastic syndromeslenalidomide krka as monotherapy is indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate. mantle cell lymphomalenalidomide krka as monotherapy is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (see sections 4. 4 in 5. follicular lymphomalenalidomide krka in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a). multiple myelomalenalidomide krka as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) je indiciran za zdravljenje odraslih bolnikov s predhodno nezdravljenih več plazmocitom, ki niso primerni za presaditev. lenalidomide krka in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. myelodysplastic syndromeslenalidomide krka as monotherapy is indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate. mantle cell lymphomalenalidomide krka as monotherapy is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (see sections 4. 4 in 5. follicular lymphomalenalidomide krka in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).
monotard
novo nordisk a/s - humani insulin - sladkorna bolezen - zdravila, ki se uporabljajo pri diabetesu - zdravljenje diabetes mellitus.
ultratard
novo nordisk a/s - humani insulin - sladkorna bolezen - zdravila, ki se uporabljajo pri diabetesu - zdravljenje diabetes mellitus.
norditropin nordiflex 10 mg/1,5 ml raztopina za injiciranje v napolnjenem injekcijskem peresniku
somatropin - raztopina za injiciranje v napolnjenem injekcijskem peresniku - somatropin 10 mg / 1,5 ml - somatropin
norditropin nordiflex 15 mg/1,5 ml raztopina za injiciranje v napolnjenem injekcijskem peresniku
somatropin - raztopina za injiciranje v napolnjenem injekcijskem peresniku - somatropin 15 mg / 1,5 ml - somatropin
norditropin nordiflex 5 mg/1,5 ml raztopina za injiciranje v napolnjenem injekcijskem peresniku
somatropin - raztopina za injiciranje v napolnjenem injekcijskem peresniku - somatropin 5 mg / 1,5 ml - somatropin
ventilastin novolizer 100 mikrogramov/odmerek prašek za inhaliranje
meda pharma gmbh & co. kg - salbutamol - prašek za inhaliranje - salbutamol 100 µg / 1 odmerek - salbutamol
nimvastid
krka, d.d., novo mesto - rivastigmin - dementia; alzheimer disease; parkinson disease - psychoanaleptics, - simptomatsko zdravljenje blage do zmerno hude alzheimerjeve demence. simptomatsko zdravljenje blage do zmerno hude demence pri bolnikih z idiopatsko parkinsonovo boleznijo.
novorapid pumpcart 100 enot/ml raztopina za injiciranje v injekcijskem vložku
novo nordisk a/s - insulin aspart - raztopina za injiciranje - insulin aspart 100 e. / 1 ml - insulin aspart